Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated:  1/25/2018
The Children's Hospital
mi
from
Denver, CO
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated: 1/25/2018
The Children's Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated:  1/25/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated: 1/25/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated:  1/25/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated: 1/25/2018
Case Western Reserve Univ
mi
from
Cleveland, OH
Click here to add this to my saved trials
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated:  1/25/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated: 1/25/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated:  1/25/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI
Status: Enrolling
Updated: 1/25/2018
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Effect of Intervention to Improve Stroke Recognition
Randomized Controlled Trial Effect of Novel Intervention to Improve Stroke Symptom Recognition
Status: Enrolling
Updated:  1/25/2018
Columbia University Medical Center
mi
from
New York, NY
Effect of Intervention to Improve Stroke Recognition
Randomized Controlled Trial Effect of Novel Intervention to Improve Stroke Symptom Recognition
Status: Enrolling
Updated: 1/25/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
One vs. Two Hand Use After Stroke: Role of Task Requirements
Status: Enrolling
Updated:  1/25/2018
Cleveland State University
mi
from
Cleveland, OH
One vs. Two Hand Use After Stroke: Role of Task Requirements
Status: Enrolling
Updated: 1/25/2018
Cleveland State University
mi
from
Cleveland, OH
Click here to add this to my saved trials
Improving Well-Being After TBI Through Structured Volunteer Activity
Improving Well-Being After TBI Through Structured Volunteer Activity
Status: Enrolling
Updated:  1/26/2018
Craig Hospital
mi
from
Englewood, CO
Improving Well-Being After TBI Through Structured Volunteer Activity
Improving Well-Being After TBI Through Structured Volunteer Activity
Status: Enrolling
Updated: 1/26/2018
Craig Hospital
mi
from
Englewood, CO
Click here to add this to my saved trials
Ketogenic Diet Therapy for Autism Spectrum Disorder
Ketogenic Diet Therapy for Autism Spectrum Disorder
Status: Enrolling
Updated:  1/26/2018
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Ketogenic Diet Therapy for Autism Spectrum Disorder
Ketogenic Diet Therapy for Autism Spectrum Disorder
Status: Enrolling
Updated: 1/26/2018
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Click here to add this to my saved trials
Ketogenic Diet Program for Epilepsy
Ketogenic Diet Program for Epilepsy
Status: Enrolling
Updated:  1/26/2018
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Ketogenic Diet Program for Epilepsy
Ketogenic Diet Program for Epilepsy
Status: Enrolling
Updated: 1/26/2018
Shriners Hospitals for Children - Honolulu
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
University of Alabama
mi
from
Birmingham, AL
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
University of California, San Diego
mi
from
San Diego, CA
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Children's Hosptial Colorado
mi
from
Aurora, CO
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Children's Hosptial Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Rush University Medical Center
mi
from
Chicago, IL
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Boston Children's Hospital
mi
from
Boston, MA
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Greenwood Genetic Center
mi
from
Greenwood, SC
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Greenwood Genetic Center
mi
from
Greenwood, SC
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Vanderbilt University
mi
from
Nashville, TN
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Baylor College of Medicine
mi
from
Houston, TX
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
UCSF Benioff Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Gillette Children's Specialty Healthcare
mi
from
Saint Paul, MN
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Gillette Children's Specialty Healthcare
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated:  1/28/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Safety Study of NNZ-2566 in Pediatric Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Dose-ranging Study of the Safety and Pharmacokinetics of Oral NNZ-2566 in Pediatric Rett Syndrome
Status: Enrolling
Updated: 1/28/2018
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH
Comparison of Short Duration Levetiracetam to Extended Course Levetiracetam for Seizure Prophylaxis Following Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/29/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Short Duration Levetiracetam to Extended Course for Seizure Prophylaxis After aSAH
Comparison of Short Duration Levetiracetam to Extended Course Levetiracetam for Seizure Prophylaxis Following Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/29/2018
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Spinal Cord Stimulation to Restore Cough
Spinal Cord Stimulation to Restore Cough
Status: Enrolling
Updated:  1/30/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Spinal Cord Stimulation to Restore Cough
Spinal Cord Stimulation to Restore Cough
Status: Enrolling
Updated: 1/30/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated:  1/30/2018
University of Miami
mi
from
Miami, FL
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated: 1/30/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated:  1/30/2018
University of Cincinnati
mi
from
Cincinnati, OH
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated: 1/30/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated:  1/30/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated: 1/30/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated:  1/30/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated: 1/30/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated:  1/30/2018
King's College Hospital
mi
from
London,
Observational Study of Cortical Spreading Depression in Human Brain Trauma
Spreading Depressions as Secondary Insults After Traumatic Injury to the Human Brain
Status: Enrolling
Updated: 1/30/2018
King's College Hospital
mi
from
London,
Click here to add this to my saved trials
Sub-study to Spinal Cord Stimulation to Restore Cough
Evaluation of Wire Electrodes to Activate the Expiratory Muscles to Restore Cough
Status: Enrolling
Updated:  1/30/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Sub-study to Spinal Cord Stimulation to Restore Cough
Evaluation of Wire Electrodes to Activate the Expiratory Muscles to Restore Cough
Status: Enrolling
Updated: 1/30/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  1/30/2018
The University Hospital
mi
from
Cincinnati, OH
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 1/30/2018
The University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated:  1/30/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
A Pilot Study Assessing the Impact of Gilenya Therapy on Bone Density Change in Relapsing Forms of Multiple Sclerosis
A Single Center Prospective, Open Label, Pilot Study to Assess Change in Bone Mass Density and Select Bone Turnover Biomarkers in Gilenya Treated Versus Non-Gilenya Treated Ambulatory Subjects With a Relapsing Form of Multiple Sclerosis
Status: Enrolling
Updated: 1/30/2018
MS Center at Evergreen Health
mi
from
Kirkland, WA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Downey, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Downey, CA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Glendale, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Chicago, IL
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Kansas City, MO
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
West Orange, NJ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
West Orange, NJ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
New York, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
New York, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
White Plains, NY
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
White Plains, NY
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Charlotte, NC
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Portland, OR
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Houston, TX
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Phoenix, AZ
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Loma Linda, CA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Loma Linda, CA
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Orlando, FL
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
Clinical Research Facility
mi
from
Tulsa, OK
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated:  1/30/2018
mi
from
Elkins Park, PA
HT-3951 vs. Placebo in Stroke Rehabilitation
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled 21-Day Treatment Study, Including an fMRI Sub-Study, to Evaluate the Effect of HT-3951 on Upper Extremity Motor Function Following Ischemic Stroke
Status: Enrolling
Updated: 1/30/2018
mi
from
Elkins Park, PA
Click here to add this to my saved trials